United Orthopedic (4129) - Cash Flow Conversion Efficiency
Based on the latest financial reports, United Orthopedic (4129) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$223.65 Million ≈ $7.05 Million USD) by net assets (NT$4.20 Billion ≈ $132.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4129 days of operational coverage to measure how many days the company can operate on defensive assets alone.
United Orthopedic - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how United Orthopedic's cash flow conversion efficiency has evolved over time, based on yearly financial data.
United Orthopedic Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of United Orthopedic ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Public Policy Holding Company, Inc. Common Stock
NASDAQ:PPHC
|
0.197x |
|
MegaStudyEdu Co. Ltd
KQ:215200
|
0.132x |
|
The Orissa Minerals Development Company Limited
NSE:ORISSAMINE
|
0.787x |
|
Polyplex (Thailand) Public Company Limited
BK:PTL-R
|
0.020x |
|
Yayla Agro Gida Sanayi ve Ticaret A.S.
IS:YYLGD
|
0.339x |
|
Minfeng Special Paper Co Ltd
SHG:600235
|
0.011x |
|
Western New England Bancorp Inc
NASDAQ:WNEB
|
0.023x |
|
Hangzhou IECHO Science & Technology Co. Ltd. A
SHG:688092
|
0.059x |
Annual Cash Flow Conversion Efficiency for United Orthopedic (2015–2025)
The table below shows the annual cash flow conversion efficiency of United Orthopedic from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 4129 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.20 Billion ≈ $132.46 Million |
NT$1.03 Billion ≈ $32.32 Million |
0.244x | +34.36% |
| 2024-12-31 | NT$3.95 Billion ≈ $124.45 Million |
NT$717.29 Million ≈ $22.60 Million |
0.182x | +63.81% |
| 2023-12-31 | NT$3.59 Billion ≈ $113.23 Million |
NT$398.43 Million ≈ $12.55 Million |
0.111x | +0.51% |
| 2022-12-31 | NT$3.09 Billion ≈ $97.35 Million |
NT$340.79 Million ≈ $10.74 Million |
0.110x | -7.03% |
| 2021-12-31 | NT$2.82 Billion ≈ $88.87 Million |
NT$334.64 Million ≈ $10.54 Million |
0.119x | -27.95% |
| 2020-12-31 | NT$2.93 Billion ≈ $92.15 Million |
NT$481.65 Million ≈ $15.17 Million |
0.165x | -1.89% |
| 2019-12-31 | NT$2.93 Billion ≈ $92.43 Million |
NT$492.45 Million ≈ $15.51 Million |
0.168x | +2943.61% |
| 2018-12-31 | NT$2.25 Billion ≈ $70.90 Million |
NT$12.41 Million ≈ $390.98K |
0.006x | +321.95% |
| 2017-12-31 | NT$2.22 Billion ≈ $69.88 Million |
NT$2.90 Million ≈ $91.33K |
0.001x | -98.68% |
| 2016-12-31 | NT$1.80 Billion ≈ $56.76 Million |
NT$179.03 Million ≈ $5.64 Million |
0.099x | -30.29% |
| 2015-12-31 | NT$1.77 Billion ≈ $55.86 Million |
NT$252.75 Million ≈ $7.96 Million |
0.143x | -- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial kn… Read more